AN2 Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -25.7% | +1,442.7% | +57.0% | +35.3% | -33.6% | -32.7% | |
| – | -25.7% | +1,319.6% | +64.1% | +12.1% | -21.9% | -30.5% | |
| – | -27.3% | +197.2% | +125.0% | -42.5% | +36.5% | -6.6% | |
| – | -27.3% | +1,338.7% | +64.0% | +11.7% | -22.1% | -30.6% | |
| – | – | – | – | – | -78.6% | +200.0% | |
| – | +67.2% | +129.8% | +110.9% | +95.4% | -27.1% | -13.2% | |
| – | +817.6% | +132.7% | +111.7% | +95.4% | -27.1% | -14.8% | |
| – | – | – | – | – | – | – | |
| – | +158.8% | +705.3% | +99.6% | +26.1% | +24.0% | -8.9% | |
| – | -42.8% | +2,150.4% | +54.1% | +30.8% | -34.4% | -35.2% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -18.1% | +53.8% | +26.4% | +1.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.